This essay argues that the federal ban on medical marijuana is unjust and counterproductive. It contends that the government should reclassify cannabis from Schedule I to Schedule II and allow physicians to prescribe it to seriously ill patients. Drawing on clinical evidence, anecdotal accounts, and legal precedent, the paper highlights marijuana's effectiveness in treating chronic pain, AIDS-related wasting, cancer-related nausea, and neurological disorders. It also addresses common objections — including overdose risk and general safety — and concludes that physician autonomy and patient welfare should take precedence over politically motivated restrictions.
A federal rule that bars doctors from easing severely ill patients' pain through marijuana prescription is an appalling, unwise, and heavy-handed policy. Federal lawmakers must revoke their ban on marijuana for clinical application in the case of acutely ailing individuals, and leave it to doctors to decide whom to prescribe this drug to. The government ought to alter marijuana's current Schedule I status — defined as potentially addictive without accepted medical utility — to Schedule II status, which recognizes a substance as possibly addictive but having accepted clinical utility, and regulate it accordingly ("Should marijuana be a medical option?").
Medical cannabis has effectively relieved pain among a number of individuals suffering from chronic ailments. Medical science researchers have only recently established the scientific effectiveness of this ancient remedy. Several thousand ailing individuals have substituted non-threatening, nontoxic cannabis for disabling psychotropic drugs such as narcotics.
A tremendous amount of anecdotal evidence has surfaced: people with injured spines can now walk without crutches or walkers; those diagnosed with AIDS have gained weight and reduced their medications; cancer patients have found relief from chemotherapy's debilitating side effect of nausea; formerly disabled individuals — disabled as a result of addictions and psychological ailments — are now reintegrated into society; and those suffering from chronic pain are functional once more, with a restoration of their consciousness from a state of narcotic lethargy, all with the aid of a nontoxic healing herb ("Should marijuana be a medical option?").
No other known drug has action mechanisms identical to marijuana. Marinol, or Dronabinol, can be obtained in capsule form via a doctor's prescription. However, its marked disadvantage is that it contains only synthetic delta-9-THC (tetrahydrocannabinol), which constitutes just one medicinally valuable cannabinoid found in natural cannabis. Curiously, this is the very drug that U.S. federal authorities have permitted physicians to administer — and it happens to contain the most psychoactive cannabinoid.
It has since been discovered that cannabinoids have neuromodulatory capacity at multiple levels of the nervous system, operating through receptor-based direct mechanisms. They possess a range of therapeutic properties — including analgesia, immunomodulation, neuroprotective and anti-oxidative effects, anti-inflammatory action, regulation of tumor growth, and glial-cell modulation — which can be applied to treat individuals suffering from neurological disorders. Furthermore, cannabinoids have been found to be remarkably safe, with no established overdose potential ("Should marijuana be a medical option?").
"No overdose deaths; safer than many prescription drugs"
"Criminalizing medical marijuana harms seriously ill patients"
"Physicians, not the DEA, should guide patient treatment"
Always verify citation format against your institution’s current style guide requirements.